Search

everythinglearnresearchcommunity

for

Search:↓

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

The protein AtRXR3 limits root hair growth in Arabidopsis, affecting phosphorus uptake.

Clofazimine may be effective for treating ashy dermatosis.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

Flutamide helps with prostate cancer and some skin conditions but can harm the liver.

Using testosterone-stimulated weanling rats can effectively replace castrated rats for anti-androgen testing, reducing animal stress.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

The combination treatment showed a higher response rate but no significant survival benefits.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Early NAS level changes affect alcohol consumption vulnerability.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Minoxidil can cause a rare eye condition, but it was successfully treated with oral Eplerenone in one case.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Nandrolone decanoate damages the heart, liver, and kidneys.

Intralesional methotrexate effectively treats alopecia areata by reducing TNF-α levels, leading to hair regrowth.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.